ACD - Global OTC Pet Medication Market

GLOBAL OTC PET MEDICATION MARKET TILL 2028 2021
OTC Pet Medication Market Analysis &

Opportunity Evaluation, 2019-2028
GLOBAL OTC PET MEDICATION MARKET TILL 2028
Methodology Followed for Calculating the Market Numbers
Bottom-Up Approach Top-Down Approach
Estimating the Market Size by

Market Size Adding up all the Revenue
Consumption of Industry Groups
Summation of (B) and (A) Percentage Break-Down by

Segments
(B) Mapping Components Market Size Value by

Segments
Percentage Break-Down by
(A) Split into Segments
Sub-Segments (If any)
Segmentation for Each Category

Market Size Value by Sub-Segments
Our team of analysts initiated with

extensive secondary research in which
several internet sources (including public
and paid sources, websites of different Extensive Secondary Research
associations involved) are glanced properly,
collecting all the qualitative insights, data,
facts and figures, charts, articles, news, etc. The crucial documents which are gathered while
doing the secondary research includes press
releases, articles, interviews, companies’ documents
Crucial Documents 2 such as annual reports, brokers report, investor
presentation/initiating coverage, call transcripts, etc.
The market size has been estimated by1 Besides, there are qualitative insights which are
collecting and analyzing the financial extracted from any authentic sources (such as
documents of the major companies involved website of the vendors, associations, distributors,
in this market. The market forecast is based etc.
upon the historical growth and trends, 3 Extraction of Numbers
current dynamics, analysis of import and
export data, analysis of the parent market Our team of analysts created a DKIP (Directory of Key
and macro-economic indicators which are Industry Participants) list comprising of the names of
impacting and will impact the growth of the the industry participants, designation, location, contact
market. number and email address of several
companies/distributors, etc. by sending them requests
Primary Research Approach 4 through LinkedIn and other sources. Based upon the
level of information gathered through internet, our
analysts developed a discussion guide (questionnaire)
and interacted with industry veterans in order to
Once all the data collected through validate the market numbers and to gather the
secondary and primary sources is verified, qualitative insights.
the regional/country-wise/segments market
numbers are calculated in excel and 5 Finalization of the Report
incorporated and presented in the
PowerPoint document along with
qualitative insights and recommendations.
Secondary Research
The process begins with extensive secondary research through various sources to carry out the qualitative and quantitative
methodologies specific to OTC pet medication market. All the secondary sources that are included in the report comprises of
government documents, legal databases, statistical reports, industry documents, company websites, annual reports, SEC filings,
financial reports, investors’ reports/presentations, comprehensive databases such as Economic Intelligence unit, press releases, and
news articles published by top industry players.
Research Components Key Secondary Sources
Company financials, magazines, press releases & journals, public and paid
Market Size
databases and repository of Research Nester
Company Information Company websites, annual report, equity research reports, and news articles
Qualitative Information Annual report, investors presentation, news articles, blogs, and industry reports
Primary Research Breakdown of Primary Interviews
The process includes research interviews of various

industry experts, veterans, and top-level people from
industry’s major players in order to authenticate and
strengthen the data and research analytics. Primary
research includes questionnaire, telephonic interviews, e-
mails, face-to-face interviews etc. The members who Others (Such as Managers, Sr. Executive)
ordinarily participate in these events (but are not restricted

Director Level
to) are Vice Presidents, Chief Executive Officers, Chief
Technical Officers, directors and marketing managers, etc. C- Level
Research Nester Analysis
After understanding the market from primary and secondary research, our analysts use their extensive years of experience in the industry to
analyze the industry outlook. Once a fair, concrete understanding of the market is developed, we help our clients to understand the market
demand and opportunity in near future through actionable insights in a dynamic marketplace environment.
TABLE OF CONTENTS
1. Introduction
1.1. Market definition
1.2. Market segmentation
1.3. Product overview
2. Assumptions and Acronyms
3. Research Methodology
3.1. Research process
3.2. Primary research
3.2.1. Manufacturers
3.2.2. End-users
3.3. Secondary research
3.4. Market size estimation
Scoping & Project Initiation Market Analysis Project Delivery
 Decipher the client requirements/  Extensive desk research to identify most relevant secondary information available.
market to be studied
 Contact Research Nester's empaneled experts and identify industry experts across the
 Tailormade research approach for
market.
customized reports
 Effective use of Research Nester's  Conduct primaries and surveys to gather qualitative and quantitative insights
knowledge repository to gather
relevant insights  Triangulate and analyze data to finalize actionable business insights
 Confirm the objectives of the
assignment with the client.  Report delivery with high quality market insights, competitive landscape, etc., as per
the proposed content.
4. Analyst Review
5. Executive Summary - Global OTC Pet Medication Market
DrugType
Drug Class
Nutraceuticals
Diphenhydramine (Bena
dryl)
H2 Receptor antagonists
5%2%
7% 10% Antidiarrheal agents
Meclizine (Dramamine)
11%
16% 26%
12% Non-steroidal anti-
inflammatory drug
Hydrocortisone
15% 11% Glucocorticosteroid
12%
Famotidine (Pepcid)
Artificial tears and ocular
22% lubricants
19% 15%
17% Aspirin
Antibacterial
Others
Antihistamine
Others
Note: The Global OTC pet medication market was valued at USD XXX million in 2019 and is expected to reach USD XXX million by 2028,
registering a CAGR of ~XX%, during the period of 2020-2028.
6. Analysis of Market Dynamics

6.1. Growth drivers
6.2. Market trends
7. Key Market Opportunities

7.1. Based on the drug type
7.2. Based on the drug class
7.3. Based on form
7.4. Based on route of administration
7.5. Based on indication
7.6. Based on pet type
7.7. Based on the distribution channel
7.8. Based on the geography
8. Major Roadblocks for the Market Growth
9. Regulatory & Standards Landscape
10. Industry Risk Analysis
11. Pricing Analysis
Drug Type Average Pricing (USD)
Diphenhydramine (Benadryl) XX
Meclizine (Dramamine) XX
Hydrocortisone XX
Famotidine (Pepcid) XX
Aspirin XX
Others XX
12. Impact of COVID-19 on the Global OTC Pet Medication Market

12.1. Impact on the overall market
12.2. Impact on the demand
12.3. Impact on the end-users
12.4. Impact on the key players in the market
12.5. Impact on overall price trend
12.6. Market impact analysis in 2020 (quarter wise) w.r.t covid-19 pandemic (USD million)
COVID Impact 1st quarter 2nd quarter 3rd quarter 4th quarter
Europe
North America
Latin America
Asia Pacific
Middle East & Africa
Global Market
13. Comparative Feature Analysis
Companies Key products Application Pet type End-user analysis Pricing analysis
UltiMed, Inc.
Zoetis Services LLC
Allison Medical
Med Trust
Merck & Co., Inc.
Boehringer Ingelheim
BD
Henry Schein, Inc.
14. Competitive Structure

14.1. Market share analysis, 2020
14.2. Competitive benchmarking

14.3. UltiMed, Inc.
14.3.1. Detailed overview
14.3.2. Assessment of key offering
14.3.3. Analysis of growth strategies

14.3.4. Production outlook
14.3.5. Exhaustive analysis on key financial indicators
14.3.6. Recent developments
14.4. Zoetis Services LLC
14.5. Allison Medical
14.6. Med Trust
14.7. Merck & Co., Inc.
14.8. Boehringer Ingelheim
14.9. BD
14.10. Henry Schein, Inc.
14.11. Other major players
15. Global OTC Pet Medication Market Outlook

15.1. By value (USD million)
16. Global OTC Pet Medication Market Segmentation Analysis 2019-
Market Segment, by Drug Type 2028
Share (in %) 2019
16.1. By drug type
15% 16.1.1. Diphenhydramine (Benadryl), 2019-2028F (USD
25%
10% million)
16.1.2. Meclizine (Dramamine), 2019-2028F (USD million)
15%
25% 16.1.3. Hydrocortisone, 2019-2028F (USD million)
10%
16.1.4. Famotidine (Pepcid), 2019-2028F (USD million)
16.1.5. Aspirin, 2019-2028F (USD million)
Diphenhydramine (Benadryl) Meclizine (Dramamine) Hydrocortisone
16.1.6. Others, 2019-2028F (USD million)
Famotidine (Pepcid) Aspirin Others
Based on drug type, the market has been divided into diphenhydramine, meclizine, hydrocortisone, famotidine, aspirin and others. The
diphenhydramine drug holds the larger share of the market in 2019 on account of growing chronic diseases in pets such as seasonal
allergies, common cold, itchy skin, and others. This type of drug is recommended to temporarily relieve symptoms of various diseases
prominent in pets. It accounts for USD $XX IN 2019 and is projected to grow at a CAGR of XX% over the forecast period.
16.2. By drug class

Market Segment, by Drug Class
16.2.1.Nutraceuticals, 2019-2028F (USD million)
Share (in %) 2019
16.2.2.H2 Receptor antagonists, 2019-2028F (USD million)
Nutraceuticals
16.2.3.Antidiarrheal agents, 2019-2028F (USD million)
H2 Receptor antagonists
16.2.4.Non-steroidal anti-inflammatory drug, 2019-2028F (USD
11% 11% Antidiarrheal agents
million)
13% 13% Non-steroidal anti-inflammatory drug
16.2.5.Glucocorticosteroid, 2019-2028F (USD million)
5% Glucocorticosteroid 16.2.6.Artificial tears and ocular lubricants, 2019-2028F (USD
12%
10% Artificial tears and ocular lubricants million)
18% 7%
Antibacterial 16.2.7.Antibacterial, 2019-2028F (USD million)
Antihistamine 16.2.8.Antihistamine, 2019-2028F (USD million)
Others
16.2.9.Others, 2019-2028F (USD million)
Based on drug class, the market has been divided into nutraceuticals, H2 receptor antagonists, antidiarrheal agents, non-steroidal anti-
inflammatory drug, glucocorticosteroid, artificial tears and ocular lubricants, antibacterial, antihistamine and others. The growing pet
ownership across the world is one of the key factors driving the growth of the market. The antibiotics and Non-steroidal anti-inflammatory
drug class is most common OTC pet medications. This drug class accounts for approximately USD $XXX million and is growing at a
CAGR of XX% and is anticipated to fuel in the upcoming forecast period.
16.3. By form
Market Segment, by Form
Share (in %) 2019 16.3.1. Chewable & tablets, 2019-2028F (USD million)
16.3.2. Capsules & ointment, 2019-2028F (USD
24% 22% million)

16.3.3. Sprays, 2019-2028F (USD million)
22%
32%
Based on form, the market has been divided into chewable &
16.4.
tablets, capsules & ointment, sprays and others, out of which, the Market Segment, by Route of Administration
Chewables & tablets Capsules & ointment Sprays Others
chewable & tablets holds the larger share. However, other Share (in %) 2019
formulations are also growing on account of changing consumer
preferences. 23%
44%
33%
Topical Oral Injectable
16.4. By route of administration

16.4.1. Topical, 2019-2028F (USD million)
16.4.2. Oral, 2019-2028F (USD million)
16.4.3. Injectable, 2019-2028F (USD million)
Based on route of administration, the market has been divided

topical, oral and injectable. The injectable segment holds a share
of XX% in 2019 and is projected to grow at a CAGR of XX%
16.5. By indication
Market Segment, by Indication
Share (in %) 2019 16.5.1. Fleas & ticks, 2019-2028F (USD million)
16.5.2. Dewormers, 2019-2028F (USD million)
16% 11% 16.5.3. Pain relief & arthritis, 2019-2028F (USD
13% million)
16.5.4. Allergies, 2019-2028F (USD million)
18%
12% 16.5.5. Insect bites, 2019-2028F (USD million)
16.5.6. Eye irritation, 2019-2028F (USD million)
11% 9%
10% 16.5.7. Diarrhea, 2019-2028F (USD million)
Fleas & ticks Dewormers Pain relief & arthritis Allergies Insect bites Eye irritation
Diarrhea Others
Based on indication, the market has been divided into fleas and ticks, dewormers, pain relief & arthritis, allergies, insect bites, eye
irritation, diarrhea and others. The fleas and ticks treatment medications segment holds a share of XX% in 2019 and is projected to
grow at a CAGR of XX% on account of major skin allergies developed due to fleas and ticks in the pet. Also, majority of pets suffer
from this type of disease a numerous times over year and it can cause serious irritation which might be a problematic for their
changing behavior.
16.6. By pet type

Market Segment, by Pet Type
Share (in %) 2019 16.6.1. Big pets, 2019-2028F (USD million)
16.6.1.1. Horse, 2019-2028F (USD million)
16.6.1.2. Sheep, 2019-2028F (USD million)
16.6.1.3. Cow, 2019-2028F (USD million)
45% 16.6.1.4. Goats, 2019-2028F (USD million)
55%
16.6.1.5. Others, 2019-2028F (USD million)
16.6.2. Small pets, 2019-2028F (USD million)
16.6.2.1. Dogs, 2019-2028F (USD million)
16.6.2.2. Cats, 2019-2028F (USD million)
Big pets Small pets
16.6.2.3. Rabbit, 2019-2028F (USD million)
Based on pet type, the market has been divided into cats, dogs, rabbits, horses, birds, and others. The growing pet ownership across the
world is one of the key factors driving the growth of the market. According to the North American Pet Health Insurance Association
(NAPHIA), nearly 85 million families in the United States (approximately 67% population) owns a pet. In 2019, dogs held the major
share of the market owing to the growing development of diabetes care products for dogs.
16.7. By distribution channel

Market Segment, by Distribution Channel
Share (in %) 2019 16.7.1. Offline, 2019-2028F (USD million)
16.7.1.1. Pet specialty stores, 2019-2028F (USD
million)
16.7.1.2. Veterinary clinics, 2019-2028F (USD
48% million)
52%
16.7.1.3. Drug & pharmacy stores, 2019-2028F (USD
million)
16.7.2. Online, 2019-2028F (USD million)
Offline Online
16.7.2.1. Company websites, 2019-2028F (USD
million)
16.7.2.2. Third party aggregators, 2019-2028F (USD million)
Based on distribution channel, the market has been divided online

and offline sales channel, out of which, the offline channel held
the larger share. However, the online channel is also growing
extensively on account of changing consumer preferences and
availability of quality drugs in online pharmacies.
16.8. By region
16.8.1. Europe, 2019-2028F (USD million)
16.8.2. North America, 2019-2028F (USD million)
16.8.3. Latin America, 2019-2028F (USD million)
16.8.4. Asia Pacific, 2019-2028F (USD million)
16.8.5. Middle East & Africa, 2019-2028F (USD million)
Regional Analysis
Market Share, by Region

Share (in %) 2019
9%
15% 30%
25%
20%
Europe North America Latin America Asia Pacific Middle East & Africa
17. Europe OTC Pet Medication Market Outlook

18. Europe OTC Pet Medication Market Segmentation Analysis 2019-2028
18.1. By drug type
18.1.1. Diphenhydramine (Benadryl), 2019-2028F (USD million)
18.1.3. Hydrocortisone, 2019-2028F (USD million)
18.2. By drug class
18.2.1. Nutraceuticals, 2019-2028F (USD million)
18.2.2. H2 Receptor antagonists, 2019-2028F (USD million)
18.2.3. Antidiarrheal agents, 2019-2028F (USD million)
18.2.4. Non-steroidal anti-inflammatory drug, 2019-2028F (USD million)
18.2.5. Glucocorticosteroid, 2019-2028F (USD million)
18.2.6. Artificial tears and ocular lubricants, 2019-2028F (USD million)
18.2.7. Antibacterial, 2019-2028F (USD million)
18.2.8. Antihistamine, 2019-2028F (USD million)
18.3. By form
18.3.1. Chewable & tablets, 2019-2028F (USD million)
18.3.2. Capsules & ointment, 2019-2028F (USD million)
18.5. By indication
18.5.1. Fleas & ticks, 2019-2028F (USD million)
18.5.3. Pain relief & arthritis, 2019-2028F (USD million)
18.5.5. Insect bites, 2019-2028F (USD million)
18.5.7. Diarrhea, 2019-2028F (USD million)
18.6. By pet type
18.6.1. Big pets, 2019-2028F (USD million)
18.6.1.3. Cow, 2019-2028F (USD million)

18.6.1.4. Goats, 2019-2028F (USD million)
18.7.1. Offline , 2019-2028F (USD million)
18.7.1.1. Pet specialty stores, 2019-2028F (USD million)
18.7.1.2. Veterinary clinics, 2019-2028F (USD million)
18.7.1.3. Drug & pharmacy stores, 2019-2028F (USD million)
18.7.2.1. Company websites, 2019-2028F (USD million)
18.7.3.
REGIONAL ANALYSIS
19. Europe OTC Pet Medication Market, By Region, 2019-2028

19.1. Western Europe, 2019-2028F (USD million)
19.2. Central Europe, 2019-2028F (USD million)
19.3. Eastern Europe, 2019-2028F (USD million)
19.4. Rest of Europe, 2019-2028F (USD million)
20. Western Europe OTC Pet Medication Market Outlook

20.1. List of key players in the region
20.2. Regulatory landscape
20.3. Pricing analysis (USD)
20.4. Market value (USD)
20.5. By drug type
20.6. By drug class
20.7. By form
20.9. By indication
20.10. By pet type
20.10.1.3. Cow, 2019-2028F (USD million)

20.11.1. Offline, 2019-2028F (USD million)
COUNTRY ANALYSIS
UK France Germany Ireland Belgium Netherlands Austria

Others
Note: The market for the major countries is analyzed with respect to market size,
segmentation, and competitive landscape
21. Central Europe OTC Pet Medication Market Outlook

21.5. By drug type
21.6. By drug class
21.7. By form
21.9. By indication
21.10. By pet type
21.10.1.3. Cow, 2019-2028F (USD million)

COUNTRY ANALYSIS
Poland Austria Slovakia Hungary Czech Republic Others
22. Eastern Europe OTC Pet Medication Market Outlook

22.5. By drug type
22.6. By drug class
22.7. By form
22.9. By indication
22.10. By pet type
22.10.1.3. Cow, 2019-2028F (USD million)

COUNTRY ANALYSIS
Belarus Ukraine Bulgaria Romania Latvia Others
23. Rest of Europe OTC Pet Medication Market Outlook

23.5. By drug type
23.6. By drug class
23.7. By form
23.9. By indication
23.10. By pet type
23.10.1.3. Cow, 2019-2028F (USD million)

COUNTRY ANALYSIS
Norway Sweden Finland Italy Spain Portugal Others
24. North America OTC Pet Medication Market Outlook

25. North America OTC Pet Medication Market Segmentation Analysis 2019-2028
25.1. By drug type
25.2. By drug class
25.3. By form

25.5. By indication
25.6. By pet type
25.6.1.3. Cow, 2019-2028F (USD million)

COUNTRY ANALYSIS
UNITED STATES CANADA
By drug type By drug type

By drug class By drug class
By form By form
By route of administration By route of administration
By indication By indication
By pet type By pet type
By distribution channel By distribution channel
*The market for the countries will be analyzed with respect to market size, market segments (same as global), and growth rate.
26. Latin America OTC Pet Medication Market Outlook

27. Latin America OTC Pet Medication Market Segmentation Analysis 2019-2028
27.1. By drug type
27.2. By drug class
27.3. By form

27.5. By indication
27.6. By pet type
27.6.1.3. Cow, 2019-2028F (USD million)

COUNTRY ANALYSIS
BRAZIL ARGENTINA
01
By form By form
04 02
MEXICO
REST OF LATAM
By drug type
By drug class By drug type
By form By drug class
By route of administration By form
03 By route of administration
By indication
By pet type By indication
By distribution channel By pet type
By distribution channel
28. Asia Pacific OTC Pet Medication Market Outlook

29. Asia Pacific OTC Pet Medication Market Segmentation Analysis 2019-2028
29.1. By drug type
29.2. By drug class
29.3. By form

29.5. By indication
29.6. By pet type
29.6.1.3. Cow, 2019-2028F (USD million)

COUNTRY ANALYSIS
REST OF ASIA PACIFIC

08 By drug type AUSTRALIA 07
By drug class By drug type
By form By drug class
By route of administration By form
By indication By route of administration
By pet type By indication
By distribution channel By pet type
06 SINGAPORE By distribution channel
JAPAN 05
By form By form
04 SOUTH KOREA VIETNAM 03
By product type By drug type
By drug type By drug class
By drug class By form
By form By route of administration
By route of administration By indication
By indication By pet type
By pet type By distribution channel
By distribution channel
INDIA 01
02 CHINABy drug type By drug type
By form By form
30. Middle East & Africa OTC Pet Medication Market Outlook
31. Middle East & Africa OTC Pet Medication Market Segmentation Analysis 2019-2028
31.1. By drug type
31.2. By drug class
31.3. By form

31.5. By indication
31.6. By pet type
31.6.1.3. Cow, 2019-2028F (USD million)

COUNTRY ANALYSIS
UAE SOUTH AFRICA

By form By form
REST OF MIDDLE EAST AND

ISRAEL AFRICA

By form By form
31.7.3.
Market Dynamics
DRIVERS RESTRAINTS
Increasing pet ownership across the High cost associated with the
01 world 01 drugs
Rising prevalence of chronic diseases in

dogs
02
TRENDS OPPORTUNITY
Development of various Increasing ownership of

OTC pet medications other pets such as birds,
horses, small animals, and
others
For more information, please contact:
Email:
Canada: +1 437 889 3230
United Kingdom: +44 203 608 5919
US Office
77 Water Street 8th Floor,
New York, New York, 10005
Phone: +1 646 586 9123
Asia Pacific Delivery Office

5th Floor, Nukleus,
Plot Number 29,
Sector 142 - Noida 201305
India.
Copyright © Research Nester. All Rights Reserved.

ACD - Global OTC Pet Medication Market

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

ACD - Global OTC Pet Medication Market

Uploaded by

Copyright:

Available Formats

GLOBAL OTC PET MEDICATION MARKET TILL 2028 2021

OTC Pet Medication Market Analysis &

Methodology Followed for Calculating the Market Numbers

Bottom-Up Approach Top-Down Approach

Estimating the Market Size by

Summation of (B) and (A) Percentage Break-Down by

(B) Mapping Components Market Size Value by

Segmentation for Each Category

Our team of analysts initiated with

Research Components Key Secondary Sources

Primary Research Breakdown of Primary Interviews

The process includes research interviews of various

ordinarily participate in these events (but are not restricted

Research Nester Analysis

Scoping & Project Initiation Market Analysis Project Delivery

6. Analysis of Market Dynamics

7. Key Market Opportunities

Drug Type Average Pricing (USD)

12. Impact of COVID-19 on the Global OTC Pet Medication Market

13. Comparative Feature Analysis

14. Competitive Structure

14.2. Competitive benchmarking

14.3.3. Analysis of growth strategies

15. Global OTC Pet Medication Market Outlook

16.2. By drug class

24% 22% million)

Topical Oral Injectable

16.4. By route of administration

Based on route of administration, the market has been divided

16% 11% 16.5.3. Pain relief & arthritis, 2019-2028F (USD

16.6. By pet type

16.7. By distribution channel

Based on distribution channel, the market has been divided online

Market Share, by Region

17. Europe OTC Pet Medication Market Outlook

18.6.1.3. Cow, 2019-2028F (USD million)

19. Europe OTC Pet Medication Market, By Region, 2019-2028

20. Western Europe OTC Pet Medication Market Outlook

20.10.1.3. Cow, 2019-2028F (USD million)

UK France Germany Ireland Belgium Netherlands Austria

21. Central Europe OTC Pet Medication Market Outlook

21.10.1.3. Cow, 2019-2028F (USD million)

Poland Austria Slovakia Hungary Czech Republic Others

22. Eastern Europe OTC Pet Medication Market Outlook

22.10.1.3. Cow, 2019-2028F (USD million)

Belarus Ukraine Bulgaria Romania Latvia Others

23. Rest of Europe OTC Pet Medication Market Outlook

23.10.1.3. Cow, 2019-2028F (USD million)

Norway Sweden Finland Italy Spain Portugal Others

24. North America OTC Pet Medication Market Outlook

25.3.2. Capsules & ointment, 2019-2028F (USD million)

25.6.1.5. Others, 2019-2028F (USD million)

UNITED STATES CANADA

By drug type By drug type

26. Latin America OTC Pet Medication Market Outlook

27.3.2. Capsules & ointment, 2019-2028F (USD million)

27.6.1.5. Others, 2019-2028F (USD million)

28. Asia Pacific OTC Pet Medication Market Outlook

29.3.2. Capsules & ointment, 2019-2028F (USD million)

29.6.1.5. Others, 2019-2028F (USD million)

REST OF ASIA PACIFIC

31.3.2. Capsules & ointment, 2019-2028F (USD million)

31.6.1.5. Others, 2019-2028F (USD million)

UAE SOUTH AFRICA